HIND - NASDAQ

Vyome Holdings, Inc.

HIND·NASDAQ

$5.73

+14%

HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$151.09M

EPS-345.7400

P/E Ratio-1.29

Earnings Date05/18/2026

4.79M

Assets

-55%

3Y-91.0%

5Y-88.0%

10Y-59.0%

5.05M

Total Liabilities

26%

3Y-38.0%

5Y-68.0%

10Y-36.0%

-253.00K

Total Equity

-104%

3Y-101.0%

5Y-101.0%

10Y-107.0%

Vyome Holdings, Inc. Funding & Solvency Profile

HIND · NASDAQ

Current Assets

Cash & Cash Equivalents693.00K

Net Receivables987.00K

Inventory2.46M

Other Current Assets114.00K

Total Current Assets5 M

Non-Current Assets

Property, Plant & Equipment154.00K

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets29.00K

Total Non-Current Assets183 K

Total Assets

4.79M

Financial Health Analysis

Current Ratio

0.92x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-397000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

96% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Vyome Holdings, Inc. Balance Sheet

HIND • NASDAQ

Vyome Holdings, Inc. Balance Sheet	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006	Dec 2005
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	693K	4.5M	3.9M	22.8M	3M	2.9M	5.5M	10.2M	3.3M	7.9M	11.6M	23.3M	22.3M	28.5M	30.8M	14.6M	21.1M	48.7M	17.5M	10.7M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	2.5M	23.3M	2.5M	9.2M	0.0	0.0	0.0	1M	0.0	0.0	5.2M	8.3M	17.2M	0.0
Cash & Short-Term Investments	693K	4.5M	3.9M	22.8M	3M	2.9M	5.5M	10.2M	3.3M	7.9M	11.6M	23.3M	22.3M	29.5M	30.8M	14.6M	26.3M	57M	34.7M	10.7M
Net Receivables	987K	1.7M	2.2M	2.8M	2.6M	4.1M	917K	488.6K	143.7K	57.9K	2.8K	0.0	52.4K	0.0	0.0	10K	77.3K	96.3K	155.5K	21.6K
Accounts Receivables	987K	1.7M	2.2M	2.8M	2.6M	4.1M	917K	488.6K	143.7K	57.9K	2.8K	17.7K	52.4K	0.0	0.0	10K	19.3K	96.3K	155.5K	21.6K
Inventory	2.5M	3.7M	3.6M	3M	2.2M	1.3M	984.7K	2.8M	1.8M	1.7M	981K	1.1M	1.3M	1.1M	0.0	-14.1M	0.0	0.0	0.0	0.0
Prepaids	334K	198K	81K	1.1M	914K	1.5M	1.1M	467.8K	476.6K	831.5K	421.7K	546.7K	571.7K	804.8K	436.5K	474.3K	421.8K	426.7K	67.6K	141.6K
Other Current Assets	114K	239K	184K	238K	209K	215K	147K	848.6K	319.0	-987.0	-171.0	0.0	200K	200K	6.5M	0.0	0.0	0.0	0.0	0.0
Total Current Assets	4.6M	10.3M	9.9M	29.9M	8.9M	10.1M	8.7M	13.9M	5.7M	10.5M	13M	25M	24.4M	31.6M	37.8M	15.1M	26.8M	57.6M	35M	10.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	154K	310K	869K	1.7M	1M	774K	63.5K	439K	201K	326K	482K	577K	610K	630.4K	742K	966K	1.3M	1.5M	1.1M	642.5K
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	260K	20.8M	27M	28.7M	36.9M	46.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	0.0	0.0	260K	20.8M	27M	28.7M	36.9M	73.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	-555K	-2.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	22K	28K	56K	555K	2.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	29K	29K	46K	1.5M	46K	99K	562.9K	989K	1.1M	759K	880K	822K	1.1M	289K	140K	146K	220.9K	5K	6.4K	36.6K
Total Non-Current Assets	205K	367K	1.2M	24M	28.1M	29.5M	37.6M	74.8M	1.3M	1.1M	1.4M	1.4M	1.7M	919.3K	882K	1.1M	1.5M	1.5M	1.1M	679.1K
Total Assets	4.8M	10.7M	11.1M	54.3M	37.1M	39.7M	46.3M	88.7M	7M	11.6M	14.4M	26.4M	26.1M	32.5M	38.7M	16.2M	28.3M	59.1M	36.1M	11.6M
LIABILITIES
CURRENT LIABILITIES
Total Payables	2.2M	1.8M	2M	3.8M	3.9M	4.3M	1.2M	1.1M	1.3M	172.1K	399.3K	127.3K	340.6K	434.4K	125.2K	33.6K	163.4K	300.3K	678.8K	316.9K
Accounts Payable	2.2M	1.7M	1.9M	3.5M	3.7M	4.3M	1.6M	1.1M	1.3M	172.1K	399.3K	127.3K	340.6K	434.4K	125.2K	33.6K	163.4K	300.3K	678.8K	316.9K
Other Payables	30K	61K	119K	326K	265K	0.0	-468K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	701K	3.9M	2.3M	2.5M	2.5M	3.8M	4.5M	2.2M	3.6M	4.3M	4.7M	4.2M	6.8M	2.9M	2.4M	3M	2.4M	1.7M	927.1K
Short Term Debt	811K	0.0	0.0	279K	3.6M	0.0	9.9M	2M	0.0	717.4K	3M	4M	3M	2.3M	922K	3.9M	2.7M	5.1M	2.7M	998.1K
Capital Lease Obligations (Current)	115K	111K	171K	279K	314K	291K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	30K	61K	119K	307K	265K	373K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	44K	510K	549K	398K	202K	352K	510K	0.0	-549.6K	-4.3M	-8.7M	-445.0	0.0	-2.9M	-6.2M	0.0	0.0	0.0	0.0
Other Current Liabilities	1.8M	1.2M	835K	321K	911K	3.1M	-6.9M	-1M	-2.2M	0.0	-4.3M	-8.7M	0.0	0.0	0.0	-6.2M	0.0	0.0	0.0	0.0
Total Current Liabilities	5M	3.8M	7.5M	7.5M	11.6M	10.4M	8.4M	1.1M	1.3M	4.5M	3.4M	127K	7.5M	9.6M	6M	34K	5.9M	7.8M	5M	2.2M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	9.2M	0.0	0.0	8M	9.9M	549.8K	0.0	2.9M	6.7M	2.9M	5M	3.9M	11M	6M	1.7M	7.3M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	64K	123K	367K	615K	702K	1.8M	5.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	20K	72K	0.0	300K	1M	4.7M	6.2M	-2.7M	-9.8M	2.9M	0.0	8.7M	0.0	0.0	-2M	6.7M	0.0	0.0	728.8K	0.0
Total Non-Current Liabilities	61K	223K	123K	667K	11M	5.2M	6.2M	11.3M	2.8M	3.4M	4.3M	11.6M	6.7M	2.9M	3M	10.6M	11M	6M	2.5M	7.3M
Other Liabilities	0.0	0.0	-2.6M	0.0	0.0	0.0	0.0	0.0	0.0	364.0	0.0	0.0	-814.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations	156K	262K	171K	279K	477K	768K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	5M	4M	7.5M	8.2M	22.6M	15.6M	14.6M	12.3M	4.1M	7.9M	7.7M	11.7M	14.2M	12.4M	9M	10.6M	16.9M	13.8M	7.5M	9.6M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	140.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	1K	1K	956.0	1K	434.0	54.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.1K	46K
Common Stock	20K	23K	1K	18K	6K	8K	87.7K	309.6K	27.4K	71.6K	695.7K	635.5K	418.4K	367.5K	278.9K	373.8K	169K	168K	5.8K	4.8K
Additional Paid-In Capital	642.6M	642.3M	627.9M	622.4M	529.4M	188.3M	450.7M	411.1M	303.9M	281.3M	258.7M	240M	211.6M	196.4M	180.1M	138.9M	112.6M	108.6M	63.4M	19.2M
Retained Earnings	-642.7M	-635.6M	-624.2M	-576.8M	-514.8M	-493.2M	-419M	-334.8M	-300.9M	-277.6M	-252.1M	-226M	-200.2M	-176.7M	-150.7M	-133.4M	-101.3M	-63.4M	-34.9M	-17.2M
Accumulated Other Comprehensive Income/Loss	-104K	-88K	-88K	-92K	-121K	-8K	-3.1M	-3M	-2.8M	-2.6M	-2.4M	-2.2M	0.0	692.0	-1.6M	0.0	13K	-41.7K	-66.5K	-87.5K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	188.3M	-562.0	131.0	434.0	-448.0	-395.0	-377.0	329.0	0.0	-57.0	-1.7K	-21.7K	0.0	0.0	0.0
Total Stockholders' Equity	-253K	6.7M	3.7M	44.3M	14.5M	24.1M	31.7M	76.4M	2.9M	3.7M	6.7M	14.7M	11.9M	20M	29.7M	5.6M	11.4M	45.3M	28.6M	2M
Total Equity	-253K	6.7M	3.7M	46.1M	14.5M	24.1M	31.7M	76.4M	2.9M	3.7M	6.7M	14.7M	11.9M	20M	29.7M	5.6M	11.4M	45.3M	28.6M	2M
SUMMARY
Total Liabilities & Equity	4.8M	10.7M	11.1M	54.3M	37.1M	39.7M	46.3M	88.7M	7M	11.6M	14.4M	26.4M	26.1M	32.5M	38.7M	16.2M	28.3M	59.1M	36.1M	11.6M
Total Investments	0.0	0.0	0.0	-555K	-2.7M	0.0	2.5M	23.3M	2.5M	9.2M	0.0	0.0	0.0	1M	0.0	0.0	5.2M	8.3M	17.2M	0.0
Total Debt	967K	262K	171K	279K	13.3M	768K	6.3M	488.6K	143.7K	1.3M	3M	6.9M	9.7M	5.2M	5.9M	7.8M	13.7M	11.1M	4.4M	8.3M
Net Debt	274K	-4.2M	-3.7M	-22.5M	-2.5M	-2.2M	762.5K	-9.7M	-3.2M	-6.7M	-8.6M	-16.4M	-12.6M	-23.3M	-24.9M	-6.9M	-7.4M	-37.6M	-13.2M	-2.4M
Shares Outstanding	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147	26,368,147

SEC Filings

HIND - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2025 N/A	November 19, 2025	November 18, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 14, 2025	September 30, 2025	2025	View Filing
S-3 S-3 N/A	November 06, 2025	November 06, 2025		View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 28, 2025	2025	View Filing
DEF 14A DEF 14A 2025 N/A	October 06, 2025	October 28, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 03, 2025	September 29, 2025	2025	View Filing
8-K/A 8-K/A 2025 (Amended) N/A	September 12, 2025	September 02, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 02, 2025	September 02, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 20, 2025	August 18, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 19, 2025	August 13, 2025	2025	View Filing

Showing 1 to 10 of 233 filings

Related Guides

Blog Categories

Continue your HIND research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.